BIOWA

BioWa, Inc., a New Jersey-based biotech company, and a wholly owned subsidiary of Kyowa Kirin Co, Ltd., was incorporated in Delaware in 2003... We find inspiration for new drug discoveries in all stages of research, development, and commercialization. Around the world, we focus on 4 different modalities with applications in our therapeutic areas of focus: therapeutic antibodies, new small-molecule drugs, nucleic-acid drugs, and regenerative medicine. In La Jolla, our lab has deep expertise and a proud legacy of discovering therapeutic antibodies for further development. The team is also working to pioneer an Open Innovation model that will help vet the potential of more discoveries... Some collaborations start small and grow to deliver extraordinary results. This has been true throughout Kyowa Kirin's history. The Kyowa Kirin-Amgen joint venture, which lasted from 1984 until 2017, resulted in the development, worldwide commercialization, and manufacturing of epoetin alfa (marketed as..

Also known as: BioWa, Inc., Kyowa Kirin Co., Ltd.

Primary location: Princeton United States